Dr. Naomi Wolf of DailyClout.io has released new information from the Pfizer documents about musculoskeletal events of special interest, or AESIs, that we now know are linked to “vaccination” with Pfizer’s mRNA Wuhan coronavirus (Covid-19) “vaccine” series.
Dubbed “Report 71,” the latest drop from Dr. Wolf was put together by Dr. Barbara Gehrett, MD, Dr. Joseph Gehrett, MD, Dr. Chris Flowers, MD, and Loree Britt.
Ben Armstrong of “The Ben Armstrong Show” also covered Report 71, along with other pertinent information that you can hear more about in the video posted at his website.”
“Report 71 is about musculoskeletal adverse events of special interest, and it turns out that they affected 8.5 percent of the post-marketing dataset in Pfizer’s database, including four children and one infant,” Dr. Wolf revealed.
“Women were affected at a ratio of almost 4:1 over men, and you’ll remember that I’ve often said that joint pain is the number-one side effect in the Pfizer documents, but the CDC doesn’t mention it.”
This would explain why so many people these days are having to get shoulder, hip, or knee replacements, or why their ankles are giving out. This includes young, otherwise healthy people who got the Pfizer jab and are now suffering from joint paint, or are limping.
“The bottom line is there were 3,600 cases of musculoskeletal adverse events, 8.5 percent, the 3,600 patients reported 3,640 adverse events of this kind,” Dr. Wolf further explained. “Of these, 44 percent were classified by Pfizer as serious, and this is actually report 71.”
Pfizer only tracked AESIs from its covid jab for 90 days following initial U.K. release on Dec. 1, 2020
Report 71 of the Pfizer documents specifically lists the group of AESIs detected as including diagnoses for arthralgia (joint pain), arthritis (joint inflammation), arthritis of a bacterial nature, chronic fatigue syndrome, polyarthritis (inflammation of multiple joints), post-viral fatigue syndrome, and rheumatoid arthritis (an autoimmune and inflammatory disease).
Keep in mind that the figures and percentages unveiled by Dr. Wolf only include those cases that were reported to and tracked by Pfizer within the first 90 days of the jab’s release starting on Dec. 1, 2020, in the United Kingdom. Nearly two weeks later, the Trump administration launched Operation Warp Speed to bring the Pfizer jab to the U.S. as well.
We know from Report 71 that the time between the jab’s administration and the onset of AESIs ranged from less than 24 hours to up to 32 days. About half of the adverse events occurred within the first 24 hours after injection.
While adults were the primary victims, there were some children and babies who also became damaged, as Dr. Wolf mentioned. Keep in mind that at the time when Pfizer administered these jabs to children, its injection had not yet been approved for use in people under the age of 16.
By far, the most common AESI reported was arthralgia (joint pain), accounting for 97 percent of cases. This was followed by 70 cases of arthritis (2 percent), 26 cases of rheumatoid arthritis (less than 1 percent), and five other AESIs involving polyarthritis (less than 1 percent).
Amazingly, Pfizer’s conclusion from all this was that “[t]his cumulative case review does not raise new safety issues,” though the company promised to continue its “surveillance” efforts, the results of which would have not been released for nearly eight decades had Pfizer gotten its way to withhold such data from the public until after the current generation of people had already long since passed away.
The latest news about the Pfizer documents can be found at ChemicalViolence.com.
Sources for this article include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.